Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

ELISIO™-HX

K-Number: K261399 · 2026-07-28

Decision Date2026-07-28
Product CodeQAX
Advisory CommitteeGU
DecisionSubstantially Equivalent

Device Summary

ELISIO™-HX is the device name listed in this FDA 510(k) record. The listed applicant is Nipro Medical Corporation. It received FDA 510(k) clearance on 2026-07-28 under 510(k) number K261399. The device is classified under product code QAX. It was reviewed by the GU advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the ELISIO™-HX?

ELISIO™-HX is a medical device that received FDA 510(k) clearance on 2026-07-28. The listed applicant is Nipro Medical Corporation. The 510(k) number is K261399.

When did ELISIO™-HX receive FDA 510(k) clearance?

ELISIO™-HX received FDA 510(k) clearance on 2026-07-28, under 510(k) number K261399.

Who is the listed applicant for ELISIO™-HX?

The FDA 510(k) record lists Nipro Medical Corporation as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for ELISIO™-HX?

The FDA product code for ELISIO™-HX is QAX.

Other records listing Nipro Medical Corporation as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

View all 12 devices →

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.